Frank C. Kuo
Brigham and Women's Hospital · 125 works · 21,080 citations · h-index 45
Top works
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- Identification and Importance of Brown Adipose Tissue in Adult Humans
- Importance of replication in microarray gene expression studies: Statistical methods and evidence from repetitive cDNA hybridizations
- The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal
- An early haematopoietic defect in mice lacking the transcription factor GATA-2
- Recurrent BRAF mutations in Langerhans cell histiocytosis
- E2F-1 Functions in Mice to Promote Apoptosis and Suppress Proliferation
- Transferrin receptor is necessary for development of erythrocytes and the nervous system
- Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors
- Isolation and Functional Analysis of a cDNA for Human Jagged2, a Gene Encoding a Ligand for the Notch1 Receptor
- Augmented Expression of a Human Gene for 8-oxoguanine DNA Glycosylase (MutM) in B Lymphocytes of the Dark Zone in Lymph Node Germinal Centers
- Institutional implementation of clinical tumor profiling on an unselected cancer population
- Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer
- Yolk sac angiogenic defect and intra‐embryonic apoptosis in mice lacking the Ets‐related factor TEL
- Loss of Daxx, a promiscuously interacting protein, results in extensive apoptosis in early mouse development
- Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18.
- The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow
- Stage-specific apoptosis, developmental delay, and embryonic lethality in mice homozygous for a targeted disruption in the murine Bloom’s syndrome gene
- Development and evaluation of an open source software tool for deidentification of pathology reports
- Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies